Please login to the form below

Not currently logged in
Email:
Password:

medicines use

This page shows the latest medicines use news and features for those working in and with pharma, biotech and healthcare.

EU’s 10-year paediatric meds report - not bad, but can do better

EU’s 10-year paediatric meds report - not bad, but can do better

label use of adult medicines in children, says the European Commission. ... In the 10 years since the Paediatric Regulation came into force, there have been 260 new medicines authorised for use in children, which an EC report says “would have not been

Latest news

  • Prix Galien opens for entries with new award Prix Galien opens for entries with new award

    In 2018, the category is open to all medicines licensed for use in the UK in the past five years. ... The Real World Evidence Award is open to all medicines that have been licensed for use in the UK in the past five years.

  • NICE expands Merck KGaA’s Erbitux reach NICE expands Merck KGaA’s Erbitux reach

    NICE expands Merck KGaA’ s Erbitux reach. Backs the medicines use for patients with SCCHN. ... After several attempts, Merck KgAa has finally persuaded the UK medicines cost-effectiveness watchdog to back its monoclonal antibody Erbitux (cetuximab),

  • NICE backs Teva's Cinqaero for severe asthma NICE backs Teva's Cinqaero for severe asthma

    Cinqaero was approved by the EMA in August 2016 for use in combination with other medicines for the maintenance treatment of severe eosinophilic asthma in adults, who have had at least ... a reduction in exacerbations or a reduction in steroid use - and

  • UK pharma launches legal challenge to NICE plans UK pharma launches legal challenge to NICE plans

    The ABPI is taking legal action to try and block NICE’s forthcoming additional access hurdle for high-cost medicines. ... The trade body said it is “important to challenge these new procedures before the first medicines get caught in the system”.

  • EMA and FDA calls for innovative approaches for Gaucher disease medicines EMA and FDA calls for innovative approaches for Gaucher disease medicines

    The joint proposal from the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) also urges the use of innovative methods in developing medicines for diseases in children ... The agencies are also encouraging the use of multi-arm

More from news
Approximately 0 fully matching, plus 272 partially matching documents found.

Latest Intelligence

  • The challenges of making genomics a reality for patients The challenges of making genomics a reality for patients

    The Chief Medical Officer’s annual report last year focused on genomics and highlighted that a fundamental shift is required in how new transformative medicines are developed and appraised for use ... Over the next seven years, Vertex anticipates

  • The challenges of making genomics a reality for patients today, not tomorrow The challenges of making genomics a reality for patients today, not tomorrow

    The Chief Medical Officer’s annual report last year focused on genomics and highlighted that a fundamental shift is required in how new transformative medicines are developed and appraised for use ... Over the next seven years, Vertex anticipates

  • Working with our healthcare system more closely is vital Working with our healthcare system more closely is vital

    NHS to make the best use of our medicines and its resources. ... Bayer, alongside our colleagues in the industry, shares the Government’s vision to ensure the UK becomes the best place in the world to discover, develop and use innovative medicines.

  • The real-world data conundrum The real-world data conundrum

    insights into the performance, clinical outcomes and safety associated with medicines use. ... All parts of the healthcare system now need a way to efficiently receive, integrate, understand, compute and use digital health data from health and social

  • Adding value in emerging markets Adding value in emerging markets

    to be made to medicines that haven’t had patent protection in decades. ... First, we listen to doctors, pharmacists and the people that use our medicines to find out their unmet needs.

More from intelligence
Approximately 1 fully matching, plus 30 partially matching documents found.

Latest appointments

  • ABPI Scotland appoints Sandra Auld as director ABPI Scotland appoints Sandra Auld as director

    the access to and use of new and innovative medicines for Scottish patients. “ ... and innovative medicines.”.

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    team. “ His experience in both government and the pharmaceutical industry will prove invaluable when addressing the issues of access and use of new medicines in the NHS and in leading discussions

  • EAHP elects Joan Peppard as president EAHP elects Joan Peppard as president

    As president of the EAHP, Peppard will look to advance the organisation's mission to develop hospital pharmacy in order to promote the best and safest use of medicines and medical

  • ABPI appoints value and access manager ABPI appoints value and access manager

    Rowland will work on a range of projects to improve patient access to innovative medicines, in line with the ABPI's strategic objectives around health technology assessment and market access. ... greater use of newer medicines,” added Catchpole.

  • Marschall Runge joins Lilly’s board of directors Marschall Runge joins Lilly’s board of directors

    Dr Runge will serve on Lilly's Science and Technology Committee and the Public Policy and Compliance Committee, where he will use his years of experience in medicines research and healthcare ... His appreciation of the importance of scientific research,

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics